The estimated Net Worth of William Kevin Fleming is at least $13.9 Milione dollars as of 21 February 2024. William Fleming owns over 3,566 units of Humana stock worth over $3,791,579 and over the last 8 years he sold HUM stock worth over $6,596,905. In addition, he makes $3,496,000 as Segment President e Clinical and Pharmacy Solutions at Humana.
Sign up
William Fleming HUM stock SEC Form 4 insiders trading
William has made over 20 trades of the Humana stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 3,566 units of HUM stock worth $1,170,326 on 21 February 2024.
The largest trade he's ever made was exercising 15,637 units of Humana stock on 4 June 2018 worth over $2,599,808. On average, William trades about 3,692 units every 85 days since 2017. As of 21 February 2024 he still owns at least 11,553 units of Humana stock.
You can see the complete history of William Fleming stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Fleming biography
Dr. William Fleming Pharm.D. serves as Segment President, Clinical and Pharmacy Solutions of the Company. He is responsible for Humana’s Clinical Solutions (strategy, quality, trend, and operations), Pharmacy Solutions (PBM, mail, specialty, retail), and Enterprise Clinical Operating Model, having held this position since December 2019. Prior to that, Dr. Fleming held positions of Segment President, Healthcare Services as well as President of the Company’s pharmacy business. Dr. Fleming joined the Company in 1994.
What is the salary of William Fleming?
As the Segment President e Clinical and Pharmacy Solutions of Humana, the total compensation of William Fleming at Humana is $3,496,000. There are 6 executives at Humana getting paid more, with Bruce Broussard having the highest compensation of $16,726,500.
How old is William Fleming?
William Fleming is 52, he's been the Segment President e Clinical and Pharmacy Solutions of Humana since 2019. There are 18 older and 11 younger executives at Humana. The oldest executive at Humana Inc. is David Jones, 70, who is the Independent Director.
What's William Fleming's mailing address?
William's mailing address filed with the SEC is HUMANA INC., 500 WEST MAIN STREET, LOUISVILLE, KY, 40202.
Insiders trading at Humana
Over the last 21 years, insiders at Humana have traded over $407,571,978 worth of Humana stock and bought 48,042 units worth $3,529,357 . The most active insiders traders include Brad D Smith, Frank A Damelio e Frank Bisignano. On average, Humana executives and independent directors trade stock every 12 days with the average trade being worth of $6,532,294. The most recent stock trade was executed by George Ii Renaudin on 1 September 2024, trading 1,241 units of HUM stock currently worth $407,284.
What does Humana do?
at humana, our cultural foundation is aligned to helping members achieve their best health by delivering personalized, simplified, whole-person healthcare experiences. recognizing healthcare needs continue to evolve for each person, for each family and for each community, humana continuously creates innovative solutions and resources that help people live their healthiest lives on their terms –when and where they need it. our employees are at the heart of making this happen and that’s why we are dedicated to building an organization of dynamic talent whose experience and passion center on putting the customer first.
What does Humana's logo look like?
Complete history of William Fleming stock trades at Humana
Humana executives and stock owners
Humana executives and other stock owners filed with the SEC include:
-
Bruce Broussard,
President, Chief Executive Officer, Director -
Brian Kane,
Chief Financial Officer -
Bruce Dale Broussard,
Pres, CEO & Director -
Christopher Hunter,
Segment President, Group and Military Business -
Alan Wheatley,
Segment President - Retail -
Timothy Huval,
Chief Administrative Officer -
William Fleming,
Segment President, Clinical and Pharmacy Solutions -
Timothy S. Huval,
Chief Admin. Officer -
T. Alan Wheatley,
Segment Pres of Retail -
Dr. William Kevin Fleming Pharm.D., PharmD, RPh,
Chief Corp. Affairs Officer & Segment Pres, Pharmacy Solutions -
Kurt Hilzinger,
Independent Chairman of the Board -
David Jones,
Independent Director -
James O'Brien,
Independent Director -
Frank Bisignano,
Independent Director -
William McDonald,
Independent Director -
Karen Katz,
Independent Director -
Frank D'Amelio,
Independent Director -
Marissa Peterson,
Independent Director -
Amy Smith,
Vice President, Investor Relations -
John Garratt,
Independent Director -
Wayne Frederick,
Independent Director -
Raquel Bono,
Independent Director -
Joseph Ventura,
Chief Legal Officer -
William Shrank,
Chief Medical and Corporate Affairs Officer -
Heather Carroll,
Chief Digital Health and Analytics Officer -
Vishal Agrawal,
Chief Strategy and Corporate Development Officer -
Sam Deshpande,
Chief Technology Officer, Chief Risk Officer -
Cynthia Zipperle,
Senior Vice President, Chief Accounting Officer, Controller -
Susan Diamond,
Segment President, Home Business -
Joseph C. Ventura,
Chief Legal Officer -
Lisa M. Stoner,
VP of Investor Relations -
Sam M. Deshpande,
Chief Information Officer -
Cynthia Hillebrand Zipperle,
Sr. VP, Chief Accounting Officer & Controller -
Susan Marie Diamond,
CFO & Segment Pres of Home Bus. -
Amy Fry,
Sr. VP of Corp. Communications -
Michael A. Koeberlein,
SVP, Chief Accting Off & Cont. -
Heather Cox,
Chief Dig Health & Analyt Off. -
Christopher E Kay,
SVP & Chief Innovation Officer -
Webster Roy Dunbar,
Director -
James E Murray,
COO-Mkt & Bus. Segment Ops -
Roy A Beveridge,,
Sr. VP & Chief Medical Officer -
Joseph William Jasser,
President, Care Delivery -
M Todoroff Christopher,
Sr. VP and General Counsel -
Jody L Bilney,
Chief Consumer Officer -
Heidi S Margulis,
Senior V.P.-Gov. Relations -
Steven E Mc Culley,
Vice President & Controller -
David Nash,
Director -
William Mitchell,
Director -
Karen B De Salvo,
Director -
Jorge S. Mesquita,
Director -
Marcy S Klevorn,
Director -
Thomas J Liston,
Sr VP-Strategy & Corp Dev -
Michael B Mccallister,
President & CEO -
Elizabeth D Bierbower,
Strategic Advisor -
James H Bloem,
Sr. VP, CFO & Treasurer -
Bruce D Perkins,
Sgmnt Pres, Health&Well-Being -
Tim S Mc Clain,
Group Pres, Govt & Other Busin -
Paul B. K. Kusserow,
Sr VP & Ch Strat Dev Officer -
Venkata R Madabhushi,
SVP & Chief Innov & Mrkting Of -
Bonnie C Hathcock,
Sr VP & Chief Human Res. Off -
W Ann Reynolds,
Director -
Jonathan T Md Lord,
Sr VP & Chief Innovation Off. -
Bruce J Goodman,
Sr VP & Chief Serv. & Info. Of -
Kathleen Pellegrino,
VP and Acting General Counsel -
James O Robbins,
Director -
Steven O Moya,
Sr. VP-Chief Marketing Officer -
Arthur P Hipwell,
Sr VP & General Counsel -
John M Bertko,
Vice President & Chief Actuary -
Michael E Gellert,
Director -
David A Sr/Ky Jones,
Director -
John R /Ky Hall,
Director -
R Eugene Shields,
Senior Vice President-Gov Prgm -
Irwin Lerner,
Director -
Brian P. Le Claire,
Strategic Advisor -
Susan D. Schick,
Seg Pres. Grp. & Military Bus. -
David T Feinberg,
Director -
M.D. Andrew C. Agwunobi,,
Seg. President, Home Solutions -
John Paul W. Felter,
SVP, Chief Accting Off & Cont. -
Brad D Smith,
Director -
George Ii Renaudin,
President, Medicare & Medicaid -
Sanjay K Shetty,
President, CenterWell -
David Dintenfass,
President, Enterprise Growth -
James A. Rechtin,
President & COO